What question did this study set out to answer?

Characterize the clinical dose-response profile and psychopharmacologic properties of N,N-dimethyltryptamine (DMT) in humans.

February 1, 1994Archives of General Psychiatry

Dose-Response Study of N,N-Dimethyltryptamine in Humans

View Full Paper

Ask AI

Bookmark

Authors

RSRuck J. StrassmanUniversity of New Mexico

Discussion

Member takes

Implication

Dose-response clinical investigation demonstrates psychopharmacologic properties of DMT in human volunteers, suggesting a quantitative baseline for evaluating receptor-active agents.

Key Points

Characterize the clinical dose-response profile and psychopharmacologic properties of N,N-dimethyltryptamine (DMT) in humans.
Gathered clinical and preliminary quantitative dose-response data following DMT administration in human subjects.
Evaluated neuropharmacological response markers to establish baseline metrics for comparing agents targeting relevant brain receptors.
Generated preliminary quantitative data delineating the human dose-response relationship of DMT.
Established foundational pharmacological parameters to enable future comparative analyses of receptor-active compounds across healthy volunteer and psychiatric cohorts.

Cite This Study

Ruck J. Strassman (1994) studied this question.

synapsesocial.com/papers/69dc58991eeef32283c0fb83 https://doi.org/10.1001/archpsyc.1994.03950020022002

View Full Paper

Ask AI

Bookmark

Implication

Dose-response clinical investigation demonstrates psychopharmacologic properties of DMT in human volunteers, suggesting a quantitative baseline for evaluating receptor-active agents.

Dose-Response Study of N,N-Dimethyltryptamine in Humans

Discussion

Member takes

Implication

Key Points

Cite This Study

Dose-Response Study of N,N-Dimethyltryptamine in Humans

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider